Neuland Laboratories Limited Share Price and Company Fundamentals
Last traded: Yesterday at 9:59 AM
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Key Metrics
PE ratio
108.69
PB ratio
12.04
Dividend yield
0.08%
Beta
-0.32
Market cap
₹195.04B
Enterprise value
₹196.02B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 1794 |
| Website | https://www.neulandlabs.com |
| Mailing address | Phoenix IVY Building 11th Floor, 5th Office Level Plot No.573A-III, Road No. 82 Jubilee Hills Hyderabad 500033 India |
| Phone / Fax | 91 40 6761 1600 / |
Dividends
Dividend yield
0.08%
Dividend amount
₹12.00
Payout ratio
8.59%
5Y Avg. yield
-%
Neuland Laboratories Limited paid ₹12.00 dividend and the ex-dividend date was 18 Jul 2025.The dividend payout ratio is 8.59%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.NEULANDLAB dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Apr 2026, following are the company executives and directors listed on Neuland Laboratories Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Davuluri Rama Mohan Rao | Executive Chairman & Chief Promoter and Member of Scientific Advisory Board | 81 | |
| Mr. Davuluri Saharsh Rao | CEO & MD | 46 | |
| Mr. Davuluri Sucheth Rao | Executive Vice Chairman | 50 | |
| Mr. Abhijit Majumdar | Chief Financial Officer | ||
| Dr. Sharadsrikar Venkatesan Kotturi | Chief Scientific Officer & Member of Scientific Advisory Board | ||
| Mr. Ajitabh Singh | Chief Information Officer | ||
| Ms. Sarada Bhamidipati | Company Secretary & Compliance Officer | ||
| Mr. Sudheer Yarabolu | Global Head Sales & BD | ||
| Mr. Hemchandra Peruvelli | Chief Human Resources Officer | 53 | |
| Mr. Sundar Narsimhan | Chief Procurement Officer | 57 |
Profitability and management effectiveness
Profit margin
2.29%
Operating margin
12.10%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Neuland Laboratories Limited is 195.04B and its enterprise value is 196.02B. The enterprise value to revenue ratio of NEULANDLAB is 32.36. The enterprise value to EBITDA ratio of NEULANDLAB is 366.95.
Neuland Laboratories Limited (NSE:NEULANDLAB) Frequently Asked Questions
1. What is Neuland Laboratories Limited's Stock Symbol?
Neuland Laboratories Limited trades on NSE under the ticker symbol "NEULANDLAB".
2. What is Neuland Laboratories Limited's stock price today?
One share of NEULANDLAB stock can currently be purchased for approximately ₹15202.
3. How can I contact Neuland Laboratories Limited?
Neuland Laboratories Limited's mailing address is Phoenix IVY Building 11th Floor, 5th Office Level Plot No.573A-III, Road No. 82 Jubilee Hills Hyderabad 500033 India. The company can be reached via phone at 91 40 6761 1600.
4. What is Neuland Laboratories Limited's official website?
The official website of Neuland Laboratories Limited is https://www.neulandlabs.com.